| Project No. |
Project |
Main Project Principal Investigator |
Affiliation |
Execution Period |
| AS-BRPT-110-01 |
Glycosidic Switch Liposomes |
Steve Roffler |
Institute of Biomedical Sciences, Institute of Biological Chemistry, Chia Nan University |
2021/1/1~2023/12/31 |
| AS-BRPT-110-02 |
Development of anti- CD33 (Siglec-3) mAb for the treatment of chronic hepatitis B infection and Alzheimer diseases |
Shie-Liang Hsieh |
Genomics Research Center |
2021/1/1~2023/12/31 |
| AS-BRPT-110-03 |
Direct Reprogramming of Human Fibroblasts into Retinal Progenitor Cells by Small Molecules to Treat Photoreceptor Degeneration |
Jean Lu |
Genomics Research Center, Tzu Chi Medical Centre |
2021/1/1~2025/12/31 |
| AS-BRPT-110-04 |
Development of potent and selective inhibitors for targeting galectins-3 and -8 in preclinical trials |
Chun-Hung Lin |
Institute of Biological Chemistry, Institute of Biomedical Sciences, Genomics Research Center |
2021/1/1~2023/12/31 |
| AS-BRPT-110-05 |
Development of Targeted Drug Delivery Systems for Cancer Molecular Imaging and Therapy |
Wen-Shan Li |
Institute of Chemistry, Biomedical Translation Research Center, Taipei Medical University, Tzu Chi Hospital |
2021/1/1~2023/12/31 |
| AS-BRPT-110-06 |
Novel Strategy for Discovery of Inhibitors against Glioblastoma |
Hsing-Pang Hsieh |
Biomedical Translation Research Center, Taipei Medical University |
2021/1/1~2023/12/31 |
| AS-BRPT-110-08 |
Platform development for manufacturing and evaluating personalized
anticancer nanoparticle vaccines |
Che-Ming Hu |
Institute of Biological Chemistry, National Taiwan University |
2021/1/1~2023/12/31 |
| AS-BRPT-110-09 |
The Development of A Popular High Efficiency Kit for Biochemical Detection of Pesticide Residues |
Yu-Chan Chao |
Institute of Molecular Biology |
2021/1/1~2021/12/31 |
| AS-BRPT-110-10 |
A High-content Microscopy System for Image-guided
Photo-induced Localized Isolation of Proteins (iPHILIP) |
Jung-Chi Liao |
Institute of Atomic and Molecular Sciences |
2021/1/1~2021/7/31 |
| AS-BRPT-110-11 |
Preclinical Studies on New Drugs for Huntington’s Disease (Revised title: Preclinical studies on new drugs for neurodegenerative diseases) |
Yi-Juang Chern |
Institute of Biomedical Sciences, Research Center for Applied Sciences, National Taiwan University |
2021/1/1~2024/12/31 |
| AS-BRPT-110-12 |
Development of Cancer Biomarkers and IVD Prototypes for Precision Oncology |
Yu-Ju Chen |
Institute of Chemistry, Institute of Statistical Science, Agricultural Biotechnology Research Center, Institute of Information Science, National Taiwan University, Taipei Medical University, Chung Shan Medical University |
2021/1/1~2023/12/31 |
| AS-BRPT-110-13 |
Exploration of New Drugs for Drug Resistant Lung Cancer and Triple-Negative Breast Cancer |
Rong-Jie Chein |
Institute of Chemistry, National Taiwan University, |
2021/1/1~2021/12/31 |
| AS-BRPT-110-14 |
Quick and Economic Urinal MicroRNA Detection System for The Diagnosis of Transitional Cell Carcinoma, Prostate Cancer |
Kuang-Li Li |
Research Center for Applied Sciences, Taipei Medical University |
2021/1/1~2023/12/31 |
| AS-BRPT-110-15 |
Drug Discovery and Evaluation System Setup for Tuberculosis (TB) and Latent TB infection |
Jiun-Jie Shie |
Institute of Chemistry, Genomics Research Center, National Taiwan University Hospital |
2021/1/1~2021/12/31 |
| AS-BRPT-110-16 |
Developing Cell-Based Apheresis for the Applications in Precision Medicine |
Ying Chih Chang |
Genomics Research Center |
2021/1/1~2023/12/31 |
| AS-BRPT-110-17 |
Development of Novel Therapeutics for Neurodegenerative Diseases-ALS and AD |
Ming-Zong Lai |
Institute of Molecular Biology |
2021/1/1~2022/12/31 |
| AS-BRPT-110-18 |
Preclinical Studies of PDIA4 Inhibitors as First-In-Class Drugs for Type 2 Diabetes |
Tzung-Yan Chen |
Agricultural Biotechnology Research Center, Taipei Medical University, Ministry of Health and Welfare |
2021/1/1~2021/12/31 |
| AS-BRPT-110-19 |
Developing Human Monoclonal Antibodies against Cancers |
Kuo-I Lin |
Genomics Research Center |
2021/1/1~2021/12/31 |
| AS-BRPT-111-01 |
Antisense oligonucleotides targeting lncRNAs as therapeutics for amyotrophic lateral sclerosis |
Hung-Chih Kuo |
Institute of Cellular and Organismic Biology |
2022/1/1~2024/12/31 |
| AS-BRPT-112-01 |
Development of Novel AhR Antagonists for Cancer Immunotherapy via Dendritic Cell Targeting |
Yung-Ling Lee |
Institute of Biomedical Sciences, Genomics Research Center, Taipei Medical University |
2023/1/1~2025/12/31 |
| AS-BRPT-112-13 |
Developing humanized antibody targeting pathogenic protein aggregates in ALS |
Yun-Ru Chen |
Genomics Research Center |
2022/1/1~2025/9/30 |
| AS-BRPT-113-01 |
Use a newly established ALS mouse model and iPSCs to develop therapeutic avenues in ALS |
Ya-Ping Yen |
Institute of Molecular Biology |
2024/1/1~2025/12/31 |
| AS-BRPT-113-03 |
Constructing and Prototyping 3D Functional Scaffolds Using Novel in-House-Developed Autopilot Single-Jet Electrospinning Platform for Tissue Engineering and Regenerative Medicine Applications |
Chia-Fu Chou |
Institute of Physics |
2024/1/1~2024/12/31 |
| AS-BRPT-113-04 |
Development of bifunctional molecule platform for the treatment of human cancer |
Hsiu-Ming Shih |
Institute of Biomedical Sciences, Research Center for Applied Sciences, National Health Research Institutes, CHANG GUNG MEMORIAL HOSPITAL |
2024/1/1~2025/12/31 |
| AS-BRPT-113-05 |
Develop humanized anti-TMCC3 antibody-drug conjugate (ADC) for targeting ovarian cancer stem cell |
Alice L. Yu |
Chang Gung Memorial Hospital |
2024/1/1~2024/12/31 |
| AS-BRPT-113-M03 |
Establishment of nucleic acid medicine-based therapy for Wilson’s disease |
Hwai-Jong Cheng |
Institute of Molecular Biology, National Taiwan University |
2024/1/1~2025/12/31 |